External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

ISBT Kuala Lumpur 2026

We will be contributing to topics related to
-
12:00 AM
Duration 60mins Kuala Lumpur, Malaysia
Residual risk of transfusion-transmitted HIV, HBV and HCV with NAT screening in Colombia, Honduras and Argentina: Application of a novel method for estimating incidence in blood donors
Eduard Grebe
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 60mins Kuala Lumpur, Malaysia
Estimating the residual risk of HIV, HBV, and HCV in blood transfusion: A comparison of calculation methods in an upper-middle-income Latin American country
Jose Yung
Notify me

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Coming soon